
Salt Lake City Angels Invests in Freyya
September 4, 2025
Salt Lake City Angels is proud to invest in Freyya, a women’s health medical device company developing a wearable, real-time rehabilitation device to monitor pelvic floor therapy for improved outcomes.
One in 4 women experiences pelvic floor disorders (PFD), and poor access to physical therapy limits treatment. Freyya is addressing PFDs with their sensor-embedded wearable that measures pelvic floor support and loading, then transmits these measurements wirelessly to a smart device, providing real-time feedback to the user and remotely to the healthcare provider.
Congrats to CEO Gabriele Niederauer, PhD, and the Freyya team on this exciting milestone.
Visit: www.freyya.com to learn more about our newest portfolio company.
And also visit www.slcangels.org to learn more about our organization.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India














